399 related articles for article (PubMed ID: 10442907)
1. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma.
Wilson MW; Hungerford JL
Ophthalmology; 1999 Aug; 106(8):1579-87. PubMed ID: 10442907
[TBL] [Abstract][Full Text] [Related]
2. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
3. Local tumor control after 106Ru brachytherapy of choroidal melanoma.
Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):385-91. PubMed ID: 15913907
[TBL] [Abstract][Full Text] [Related]
4. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study.
Kivelä T; Puusaari I; Damato B
Ophthalmology; 2003 Nov; 110(11):2235-44. PubMed ID: 14597535
[TBL] [Abstract][Full Text] [Related]
5. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
[TBL] [Abstract][Full Text] [Related]
6. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma.
Jensen AW; Petersen IA; Kline RW; Stafford SL; Schomberg PJ; Robertson DM
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):101-8. PubMed ID: 16111577
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study.
Sobrin L; Schiffman JC; Markoe AM; Murray TG
Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708
[TBL] [Abstract][Full Text] [Related]
8. 125I plaque brachytherapy for anterior uveal melanomas.
Lumbroso-Le Rouic L; Charif Chefchaouni M; Levy C; Plancher C; Dendale R; Asselain B; Solignac S; Mazal A; Desjardins L
Eye (Lond); 2004 Sep; 18(9):911-6. PubMed ID: 15002010
[TBL] [Abstract][Full Text] [Related]
9. Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma.
Isager P; Ehlers N; Urbak SF; Overgaard J
Acta Oncol; 2006; 45(3):285-93. PubMed ID: 16644571
[TBL] [Abstract][Full Text] [Related]
10. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
[TBL] [Abstract][Full Text] [Related]
12. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
[TBL] [Abstract][Full Text] [Related]
13. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
15. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
16. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
[TBL] [Abstract][Full Text] [Related]
17. Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch's membrane rupture.
Mashayekhi A; Tuncer S; Shields CL; Shields JA
Ophthalmology; 2010 May; 117(5):1013-23. PubMed ID: 20097428
[TBL] [Abstract][Full Text] [Related]
18. The comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone.
Yarovoy AA; Magaramov DA; Bulgakova ES
Brachytherapy; 2012; 11(3):224-9. PubMed ID: 22104351
[TBL] [Abstract][Full Text] [Related]
19. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
Finger PT; Berson A; Szechter A
Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
[TBL] [Abstract][Full Text] [Related]
20. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
Stoffelns BM; Kutzner J; Jochem T
Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
